Neuroprotective effects of (Β±)-kavain in
β
Nicole Schmidt; Boris Ferger
π
Article
π
2001
π
John Wiley and Sons
π
English
β 319 KB
π 2 views
This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o